BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15525793)

  • 1. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation.
    Park SY; Lee JH; Kim YK; Kim CD; Rhim BY; Lee WS; Hong KW
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1241-8. PubMed ID: 15525793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation.
    Park SY; Lee JH; Kim CD; Lee WS; Park WS; Han J; Kwak YG; Kim KY; Hong KW
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1238-45. PubMed ID: 16547169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.
    Lee JH; Oh GT; Park SY; Choi JH; Park JG; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
    J Pharmacol Exp Ther; 2005 May; 313(2):502-9. PubMed ID: 15734902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.
    Shin HK; Kim YK; Kim KY; Lee JH; Hong KW
    Circulation; 2004 Mar; 109(8):1022-8. PubMed ID: 14967724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
    Hattori Y; Suzuki K; Tomizawa A; Hirama N; Okayasu T; Hattori S; Satoh H; Akimoto K; Kasai K
    Cardiovasc Res; 2009 Jan; 81(1):133-9. PubMed ID: 18703532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4/NF-κB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells.
    Feng Y; Cai ZR; Tang Y; Hu G; Lu J; He D; Wang S
    Genet Mol Res; 2014 Jan; 13(1):680-95. PubMed ID: 24615033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of TLR4/NF-kappaB activation and LOX-1 on monocyte adhesion to endothelium].
    Wang HY; Qu P; Lu S; Liu M; Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):827-31. PubMed ID: 16266460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.
    Li D; Chen H; Romeo F; Sawamura T; Saldeen T; Mehta JL
    J Pharmacol Exp Ther; 2002 Aug; 302(2):601-5. PubMed ID: 12130721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells.
    Li D; Mehta JL
    Circulation; 2000 Jun; 101(25):2889-95. PubMed ID: 10869259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
    Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
    Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions.
    Kawakami A; Tanaka A; Nakajima K; Shimokado K; Yoshida M
    Circ Res; 2002 Aug; 91(3):263-71. PubMed ID: 12169653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mulberry leaf aqueous fractions inhibit TNF-alpha-induced nuclear factor kappaB (NF-kappaB) activation and lectin-like oxidized LDL receptor-1 (LOX-1) expression in vascular endothelial cells.
    Shibata Y; Kume N; Arai H; Hayashida K; Inui-Hayashida A; Minami M; Mukai E; Toyohara M; Harauma A; Murayama T; Kita T; Hara S; Kamei K; Yokode M
    Atherosclerosis; 2007 Jul; 193(1):20-7. PubMed ID: 17055514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of LOX-1 on expression of adhesion molecules induced by ox-LDL in HUVECs].
    Zhu HL; Xia M; Hou MJ; Tang ZH; Zheng PY; Ling WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):743-7. PubMed ID: 16188066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells.
    Sakamoto N; Ishibashi T; Sugimoto K; Sawamura T; Sakamoto T; Inoue N; Saitoh S; Kamioka M; Uekita H; Ohkawara H; Suzuki K; Teramoto T; Maruyama Y; Takeishi Y
    J Cell Physiol; 2009 Sep; 220(3):706-15. PubMed ID: 19452449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
    Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
    J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
    Zhao W; Ma G; Chen X
    Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors.
    Li D; Mehta JL
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1116-22. PubMed ID: 10764682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism.
    Lee HS; Lee MJ; Kim H; Choi SK; Kim JE; Moon HI; Park WH
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):720-9. PubMed ID: 20163327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor-alpha-stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways.
    Chen JW; Chen YH; Lin SJ
    Free Radic Biol Med; 2006 Mar; 40(5):817-26. PubMed ID: 16520234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.